Viewing StudyNCT06422858

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422858
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2024-05-09
Brief Title: Sequential Tegafur-gimeracil-oteracil Potassium Capsule s-1 and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Sponsor: Zhejiang Cancer Hospital
Organization: Zhejiang Cancer Hospital
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma
Keywords: